Bullous Pemphigoid - 29 Studies Found

Terminated : Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous Pemphigoid
: Bullous Pemphigoid
: 2012-04-04
: Drug: DF2156A DF2156A is a novel small molecule that inhibits the biological activity of the CXC ligand
Recruiting : Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid
: Bullous Pemphigoid
: 2016-06-24
:
  • Drug: treatment with topical superpotent corticosteroid therapy
Not yet recruiting : Ixekizumab in the Treatment of Bullous Pemphigoid
:
  • Bullous Pemphigoid
  • Pemphigoid

    • : 2017-03-21
    : Drug: Ixekizumab Subcutaneous injection Other Name:
Completed : Genetic Susceptibility and Influence of the Microbiomae in Bullous Pemphigoid
: Bullous Pemphigoid
: 2016-08-11
: Other: Blood sample and cotton skin swabs
Completed : Anti-IL-5 Therapy in Bullous Pemphigoid (BP)
: Pemphigoid, Bullous
: 2012-10-05
:
  • Drug: Mepolizumab (a-IL-5 antibody)

Completed : Explore the Mechanisms of Pruritus in Bullous Pemphigoid Patients During Remission
:
  • Bullous Pemphigoid
  • Pruritus

: 2010-12-21
Completed : Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid
: Pemphigoid, Bullous
: 2014-07-27
: Biological: Bertilimumab
Completed : Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid
: Bullous Pemphigoid
: 2015-01-07
:
  • Procedure: Impedance analysis

Completed : Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid
: Ocular Cicatricial Pemphigoid
: 2007-12-26
: Drug: Rituximab The Rituximab dose is 1000mg (1gm) given as an IV infusion every two weeks for 2 doses (
Completed : Pruritus and Pemphigoid in Nursing Home Patients
:
  • Pemphigoid
  • Pruritus

: 2016-06-28
: Other: Blood sample One extra blood sample of 10 ml will be taken during a routine venapunction for immu
<<< Previous | Next >>>